BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Approved
DIN Number
02498103
Drug Class
Human
Market Date
May 28, 2021
Company
HC
Mylan Pharmaceuticals ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02498103
AIG Number0153268001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01AA09 BENDAMUSTINE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
BENDAMUSTINE HYDROCHLORIDEActive
Strength: 25 MG / VIAL
Monograph: BENDAMUSTINE HYDROCHLORIDE